JP2005536507A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536507A5
JP2005536507A5 JP2004521592A JP2004521592A JP2005536507A5 JP 2005536507 A5 JP2005536507 A5 JP 2005536507A5 JP 2004521592 A JP2004521592 A JP 2004521592A JP 2004521592 A JP2004521592 A JP 2004521592A JP 2005536507 A5 JP2005536507 A5 JP 2005536507A5
Authority
JP
Japan
Prior art keywords
alkyl
pyrrolo
compound
pyridazine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004521592A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/021493 external-priority patent/WO2004006836A2/en
Publication of JP2005536507A publication Critical patent/JP2005536507A/ja
Publication of JP2005536507A5 publication Critical patent/JP2005536507A5/ja
Pending legal-status Critical Current

Links

JP2004521592A 2002-07-11 2003-07-08 6H−ピロロ[3,4−d]ピリダジン化合物による神経障害性疼痛の治療 Pending JP2005536507A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39473402P 2002-07-11 2002-07-11
PCT/US2003/021493 WO2004006836A2 (en) 2002-07-11 2003-07-08 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds

Publications (2)

Publication Number Publication Date
JP2005536507A JP2005536507A (ja) 2005-12-02
JP2005536507A5 true JP2005536507A5 (cg-RX-API-DMAC7.html) 2006-04-20

Family

ID=30115760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004521592A Pending JP2005536507A (ja) 2002-07-11 2003-07-08 6H−ピロロ[3,4−d]ピリダジン化合物による神経障害性疼痛の治療

Country Status (6)

Country Link
US (1) US7465730B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539168A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005536507A (cg-RX-API-DMAC7.html)
AU (1) AU2003248907B2 (cg-RX-API-DMAC7.html)
CA (1) CA2492022A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004006836A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047759A1 (es) 2003-09-26 2006-02-22 Vertex Pharma Derivados de fenil - piperazina como moduladores de receptores muscarnicos
GB0405200D0 (en) * 2004-03-08 2004-04-21 Pfizer Ltd Combinations comprising alpha-2-delta ligands
AU2006294579A1 (en) 2005-09-27 2007-04-05 Myriad Genetics, Inc. Pyrrole derivatives as therapeutic compounds
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途
TW200914457A (en) * 2007-05-31 2009-04-01 Kyowa Hakko Kogyo Kk Pyrimidodiazepinone derivative
KR101335784B1 (ko) 2007-09-28 2013-12-05 다이이찌 산쿄 가부시키가이샤 2 고리성 γ-아미노산 유도체
EP3106166B1 (en) 2008-02-29 2020-12-02 VM Therapeutics LLC Compounds for treating pain syndrome and other disorders
EP2313102A2 (en) 2008-07-03 2011-04-27 Biota Scientific Management Bycyclic nucleosides and nucleotides as therapeutic agents
GB0813144D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
WO2010110361A1 (ja) 2009-03-26 2010-09-30 第一三共株式会社 二環性γ-アミノ酸誘導体の製造方法
BR112013031360B1 (pt) 2011-06-08 2022-01-25 Daiichi Sankyo Company, Limited Método para produzir um composto
ES2649968T3 (es) 2011-06-08 2018-01-16 Daiichi Sankyo Company, Limited Procedimiento de producción de un compuesto bicíclico vía transposición de Claisen
HUE040225T2 (hu) 2011-12-15 2019-02-28 Daiichi Sankyo Co Ltd Eljárás biciklikus vegyület optikai elválasztására aszimmetrikus katalizátort felhasználva
HUE033397T2 (en) 2012-04-10 2017-12-28 Daiichi Sankyo Co Ltd A method for the optical separation of bicyclic compounds by an enzyme
WO2014069626A1 (ja) * 2012-11-01 2014-05-08 協和発酵キリン株式会社 ピリミドジアゼピノン化合物の製造方法
EP2928891B1 (en) 2012-12-04 2019-02-20 Rigel Pharmaceuticals, Inc. Protein kinase c inhibitors and uses thereof
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ-胺基酸衍生物及其製造方法
EP3548489A1 (en) * 2016-11-30 2019-10-09 Esteve Pharmaceuticals, S.A. Ortho substituted phenylpyrazolo- and phenylpyrrolo-pyridazine derivatives having multimodal activity against pain
WO2018100041A1 (en) * 2016-11-30 2018-06-07 Laboratorios Del Dr. Esteve, S.A. Meta substituted phenylpyrazolo- and phenylpyrrolo- pyridazine derivatives having multimodal activity against pain
EP3630765A1 (en) * 2017-05-30 2020-04-08 Esteve Pharmaceuticals, S.A. Substituted pyrrolidinyl and piperidinyl pyrazolopyridazine derivatives having multimodal activity against pain
WO2021239558A1 (en) 2020-05-27 2021-12-02 Esteve Pharmaceuticals, S.A. Pyrazolo[1,5-a]pyrimidine derivatives having multimodal activity against pain
GB202106872D0 (en) * 2021-05-13 2021-06-30 Addex Pharmaceuticals Sa Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use

Similar Documents

Publication Publication Date Title
US12331052B2 (en) Organic compounds
AU2018307480B2 (en) Organic compounds
AU2018307479B2 (en) Organic compounds
RU2095062C1 (ru) Блокатор синдрома отмены, являющегося результатом привыкания к чрезмерному потреблению лекарств или веществ, вызывающих привыкание, фармакологическая композиция на его основе и способ облегчения или предотвращения синдрома отмены
JP2007509150A5 (cg-RX-API-DMAC7.html)
JP2006522128A5 (cg-RX-API-DMAC7.html)
CA3134674A1 (en) Methods of treating neuropathic pain
CN120417904A (zh) 作用于血清素5-HT2A受体的杂环稠合γ-咔啉
JP2005533007A5 (cg-RX-API-DMAC7.html)
PT1003494E (pt) ( d ) -metadona, um analgésico não opióide.
CN1527711A (zh) 用于药物治疗成瘾性物质或麻醉剂成瘾的活性成分组合物
JP5134755B2 (ja) 4−(オキサゾロピリジン−2−イル)−1,4−ジアザビシクロ−[3.2.2]ノナン誘導体、それらの製造と治療的使用
KR20230017361A (ko) 중수소화 덱스트로메토르판의 합성 방법
JP2575569B2 (ja) 薬物従属症及び禁断症状の治療に関するグリシン/nmdaレセプターリガンドの用法
JP3123080B2 (ja) 「インドール誘導体およびその医薬用途」
JP2008094795A (ja) 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤
JP4292738B2 (ja) インドール誘導体およびその医薬用途
US5714483A (en) Antitussive
Cai et al. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3 R)-7-hydroxy-N-((1 S)-1-{[(3 R, 4 R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1-piperidinyl] methyl}-2-methylpropyl)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide (JDTic)
AU2006239813B2 (en) Opioid receptor agonist compounds and their use in treatment of pain
KR100977332B1 (ko) 5-(피리딘-3-일)-1-아자비시클로[3.2.1]옥탄의 유도체,그의 제법 및 치료 용도
MX2010009110A (es) Beloxepina, sus enantiomeros, y analogos de la misma para el tratamiento de dolor.
Owen et al. Almorexant
CA2248134A1 (en) Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers
JP2015500293A5 (cg-RX-API-DMAC7.html)